MOODY ALDRICH PARTNERS LLC - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 288 filers reported holding CONMED CORP in Q2 2024. The put-call ratio across all filers is 2.56 and the average weighting 0.1%.

Quarter-by-quarter ownership
MOODY ALDRICH PARTNERS LLC ownership history of CONMED CORP
ValueSharesWeighting
Q4 2023$4,281,841
-18.8%
39,100
+0.7%
0.77%
-24.8%
Q2 2023$5,273,891
+30.7%
38,810
-0.1%
1.02%
+25.8%
Q1 2023$4,033,922
-12.3%
38,840
-25.1%
0.81%
-12.7%
Q4 2022$4,599,086
-20.3%
51,885
-27.9%
0.93%
-21.5%
Q3 2022$5,772,000
-14.4%
72,000
+2.3%
1.19%
-10.3%
Q2 2022$6,742,000
-34.4%
70,401
+1.7%
1.32%
-8.4%
Q1 2022$10,284,000
+30.3%
69,230
+24.4%
1.45%
+31.5%
Q4 2021$7,891,000
+13.2%
55,663
+4.5%
1.10%
+24.4%
Q3 2021$6,968,000
+11.0%
53,257
+16.6%
0.88%
+0.2%
Q2 2021$6,276,000
-19.9%
45,667
-23.9%
0.88%
-21.9%
Q1 2021$7,834,000
+18.5%
59,993
+1.7%
1.13%
+5.9%
Q4 2020$6,609,000
+110.6%
59,005
+47.9%
1.07%
+62.7%
Q3 2020$3,138,000
+56.8%
39,891
+43.5%
0.66%
+54.4%
Q2 2020$2,001,000
+47.3%
27,799
+17.2%
0.42%
+3.7%
Q1 2020$1,358,000
-48.9%
23,720
-0.2%
0.41%
-24.9%
Q4 2019$2,658,000
+17.3%
23,770
+0.9%
0.55%
-9.5%
Q3 2019$2,266,000
+11.1%
23,564
-1.1%
0.60%
+15.7%
Q2 2019$2,039,000
-60.8%
23,834
-61.9%
0.52%
-64.3%
Q1 2019$5,205,000
+208.9%
62,579
+138.4%
1.46%
+164.2%
Q4 2018$1,685,000
-12.8%
26,253
+7.7%
0.55%
-0.7%
Q3 2018$1,932,000
+29.1%
24,387
+19.3%
0.56%
+4.7%
Q2 2018$1,497,00020,4460.53%
Other shareholders
CONMED CORP shareholders Q2 2024
NameSharesValueWeighting ↓
Iron Triangle Partners LP 190,000$24,858,0003.57%
Ranger Investment Management 253,789$33,203,0001.77%
EARNEST PARTNERS LLC 1,603,130$209,737,0001.28%
Penn Capital Management Company, LLC 92,086$12,048,0001.22%
Champlain Investment Partners, LLC 1,492,419$195,253,0000.94%
MOODY ALDRICH PARTNERS LLC 53,257$6,968,0000.88%
Hood River Capital Management LLC 215,384$28,179,0000.87%
OAK RIDGE INVESTMENTS LLC 71,880$9,404,0000.83%
WAFRA INC. 138,542$18,125,0000.66%
EPIQ PARTNERS, LLC 10,463$1,369,0000.63%
View complete list of CONMED CORP shareholders